PMID- 25439749 OWN - NLM STAT- MEDLINE DCOM- 20160506 LR - 20181202 IS - 1532-2653 (Electronic) IS - 0967-5868 (Linking) VI - 22 IP - 1 DP - 2015 Jan TI - A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: increasing glutamate uptake with PPARgamma agonists. PG - 21-8 LID - S0967-5868(14)00556-6 [pii] LID - 10.1016/j.jocn.2014.09.001 [doi] AB - The established role of glutamate in the pathogenesis of glioma-associated seizures (GAS) led us to investigate a novel treatment method using an established drug class, peroxisome proliferator activated receptor (PPAR) gamma agonists. Previously, sulfasalazine has been shown to prevent release of glutamate from glioma cells and prevent GAS in rodent models. However, raising protein mediated glutamate transport via excitatory amino acid transporter 2 (EAAT2) has not been investigated previously to our knowledge. PPAR gamma agonists are known to upregulate functional EAAT2 expression in astrocytes and prevent excitotoxicity caused by glutamate excess. These agents are also known to have anti-neoplastic mechanisms. Herein we discuss and review the potential mechanisms of these drugs and highlight a novel potential treatment for GAS. CI - Crown Copyright (c) 2014. Published by Elsevier Ltd. All rights reserved. FAU - Ching, Jared AU - Ching J AD - Department of Surgery, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, UK. Electronic address: jared.ching@nhs.net. FAU - Amiridis, Stephanie AU - Amiridis S AD - Department of Surgery, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia. FAU - Stylli, Stanley S AU - Stylli SS AD - Department of Surgery, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, Australia. FAU - Morokoff, Andrew P AU - Morokoff AP AD - Department of Surgery, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, Australia. FAU - O'Brien, Terence J AU - O'Brien TJ AD - Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia. FAU - Kaye, Andrew H AU - Kaye AH AD - Department of Surgery, The University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, Australia. LA - eng PT - Journal Article PT - Review DEP - 20141122 PL - Scotland TA - J Clin Neurosci JT - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia JID - 9433352 RN - 0 (Antineoplastic Agents) RN - 0 (Excitatory Amino Acid Transporter 2) RN - 0 (PPAR gamma) RN - 3KX376GY7L (Glutamic Acid) SB - IM MH - Animals MH - Antineoplastic Agents/*pharmacology MH - Brain Neoplasms/complications/*drug therapy MH - Excitatory Amino Acid Transporter 2/*metabolism MH - Glioblastoma/complications/*drug therapy MH - Glutamic Acid/*metabolism MH - Humans MH - PPAR gamma/*agonists/metabolism MH - Seizures/*drug therapy/etiology OTO - NOTNLM OT - Glioma OT - Glutamate OT - PPAR gamma OT - Seizures EDAT- 2014/12/03 06:00 MHDA- 2016/05/07 06:00 CRDT- 2014/12/03 06:00 PHST- 2014/05/26 00:00 [received] PHST- 2014/08/30 00:00 [revised] PHST- 2014/09/02 00:00 [accepted] PHST- 2014/12/03 06:00 [entrez] PHST- 2014/12/03 06:00 [pubmed] PHST- 2016/05/07 06:00 [medline] AID - S0967-5868(14)00556-6 [pii] AID - 10.1016/j.jocn.2014.09.001 [doi] PST - ppublish SO - J Clin Neurosci. 2015 Jan;22(1):21-8. doi: 10.1016/j.jocn.2014.09.001. Epub 2014 Nov 22.